DiNardo CD, Pratz KW, Panayiotidis P, Wei X, et al. The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia. Am J Hematol 2024 Nov 1. doi: 10.1002/ajh.27515.
PMID: 39487568